From: The impact of treatment delay on skin cancer in COVID-19 era: a case-control study
Variables | BCC | p value | SCC | p value | NMSC | p value | |||
---|---|---|---|---|---|---|---|---|---|
2020 | 2019 | 2020 | 2019 | 2020 | 2019 | ||||
No. patients | 78 | 74 | Â | 55 | 29 | Â | 133 | 103 | 0.04 |
NCCN risk group | Â | Â | 0.44 | Â | Â | 0.69 | Â | Â | Â |
 Low | 4 | 2 | 1 | 0 |  |  |  | ||
 High | 74 | 72 | 27 | 13 | |||||
 Very high |  |  | 27 | 16 | |||||
T category | Â | Â | 0.72 | Â | Â | 0.56 | Â | Â | 0.71 |
 1 | 64 | 57 | 29 | 16 | 93 | 73 | |||
 2 | 12 | 14 | 19 | 9 | 31 | 23 | |||
 3 | 2 | 3 | 7 | 3 | 9 | 6 | |||
 4 | 0 | 0 | 0 | 1 | 0 | 1 | |||
Diameter (mm) | 12.45 + 8.67 | 13.48 + 9.48 | 0.50 | 22.00 + 18.56 | 23.75 + 18.13 | 0.47 | Â | Â | Â |
Positive margin | Â | Â | 0.57 | Â | Â | 0.53 | Â | Â | 0.73 |
 No | 64 | 58 | 48 | 27 | 112 | 85 | |||
 Yes | 14 | 16 | 7 | 2 | 21 | 18 | |||
Degree of differentiation | Â | Â | - | Â | Â | 0.73 | - | - | - |
 1 |  |  | 21 | 9 |  |  | |||
 2 |  |  | 20 | 13 |  |  | |||
 3 |  |  | 14 | 7 |  |  | |||
Reconstruction typea | Â | Â | 0.036 | Â | Â | 0.14 | Â | Â | 0.006 |
 Primary repair | 22 | 33 | 11 | 10 | 33 | 43 | |||
 Skin grafting | 17 | 15 | 16 | 8 | 33 | 23 | |||
 Flap | 39 | 26 | 28 | 11 | 67 | 37 |